Efficacy of anakinra in a case of refractory Still disease.
Debiais
Severine
S
CHRU de Tours, Service de Médecine Interne, Tours, France. debiais@med.univ-tours.fr
Maillot
Francois
F
Luca
Luminita
L
Buret
Jennifer
J
Fautrel
Bruno
B
Renard
Jean Paul
JP
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects / Q000627:therapeutic use*; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein